Callable Multi Defender Vonti

Symbol: RMARNV
ISIN: CH1341846694
Issuer:
Bank Vontobel
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 101.40
Diff. absolute / % -1.80 -1.74%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Callable Multi Defender Vonti
ISIN CH1341846694
Valor 134184669
Symbol RMARNV
Quotation in percent Yes
Coupon p.a. 10.00%
Coupon Premium 5.03%
Coupon Yield 4.97%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency US Dollar
First Trading Date 23/05/2024
Date of maturity 24/11/2025
Last trading day 17/11/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded No
Pricing Dirty
Issuer Bank Vontobel

Key data

Ask Price (basis for calculation) 101.5000
Maximum yield 10.88%
Maximum yield p.a. 10.82%
Sideways yield 10.88%
Sideways yield p.a. 10.82%

market maker quality Date: 20/11/2024

Average Spread 0.98%
Last Best Bid Price 102.70 %
Last Best Ask Price 103.70 %
Last Best Bid Volume 500,000
Last Best Ask Volume 500,000
Average Buy Volume 142,905
Average Sell Volume 142,905
Average Buy Value 146,961 USD
Average Sell Value 148,391 USD
Spreads Availability Ratio 98.58%
Quote Availability 98.58%

Underlyings

Name Johnson & Johnson Bristol-Myers Squibb Co. Medtronic Inc.
ISIN US4781601046 US1101221083 IE00BTN1Y115
Price 148.94 EUR 56.48 EUR 82.725 EUR
Date 22/11/24 22:59 22/11/24 22:59 22/11/24 22:59
Cap 154.64 USD 44.03 USD 85.92 USD
Distance to Cap 2.38 14.57 -0.580004
Distance to Cap in % 1.52% 24.86% -0.68%
Is Cap Level reached No No No
Barrier 85.05 USD 24.22 USD 47.26 USD
Distance to Barrier 71.97 34.38 38.08
Distance to Barrier in % 45.83% 58.67% 44.62%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.